Sign In
Buy JNJ
$241.00
+1.92 (+0.80%)
At Close: Jun 24, 2026
Time to Pounce: 2 High-Yielding Dow Stocks That Are Begging to Be Bought Right Now
04:41am, Tuesday, 11'th Jun 2024
Few investment strategies have performed better over the long-run than buying and holding high-quality dividend stocks. The 128-year-old Dow Jones Industrial Average is packed with time-tested, multin
The 3 Best Dow Stocks to Buy in June 2024
12:39pm, Friday, 07'th Jun 2024
As we enter June 2024, the Dow Jones Industrial Average continues to be a closely watched barometer of the U.S. stock market. In this article, we will explore the three best Dow stocks to consider add
J&J-backed Rapport Therapeutics valued at $636.8 mln after shares rise 6% in debut
11:48am, Friday, 07'th Jun 2024
Shares of Rapport Therapeutics , backed by Johnson & Johnson's venture capital arm, rose nearly 6% in their market debut on Friday, valuing the early stage therapy developer at $636.8 million.
4 Dividend Aristocrats To Buy In June And 4 To Watch
08:50am, Friday, 07'th Jun 2024
"Dividend Aristocrats
The Dividend Darlings: 3 Stocks That Will Shower Your Portfolio with Cash
07:10am, Friday, 07'th Jun 2024
From 1930 to 2023, 70% of dividend stocks in the top two quintiles outperformed the S&P 500 during recessions. Dividends have contributed 40% of the stock market gain since 1930, increasing with risin
3 Dow Stocks That Are No-Brainer Buys in June
04:21am, Friday, 07'th Jun 2024
Over 128 years, the Dow has evolved from a 12-stock industrial index into one that features 30 time-tested, multinational businesses. Patient investors can still find value in the Dow Jones Industrial
J&J-backed Rapport Therapeutics raises $136 mln in US IPO
07:57pm, Thursday, 06'th Jun 2024
Rapport Therapeutics said on Thursday that it has raised $136 million in its initial public offering in the United States at a valuation of about $601.4 million.
Johnson & Johnson (JNJ) Stock Drops Despite Market Gains: Important Facts to Note
06:46pm, Wednesday, 05'th Jun 2024
Johnson & Johnson (JNJ) closed at $145.97 in the latest trading session, marking a -1.24% move from the prior day.
J&J (JNJ) Seeks Expanded Use of HIV Drug in US and Europe
10:51am, Wednesday, 05'th Jun 2024
J&J (JNJ) seeks expanded use of its HIV-1 therapy, Prezcobix, for younger kids in the United States and Europe.
Buy 1 June Dow Dog, And Watch 3
10:27am, Wednesday, 05'th Jun 2024
"The Dow® [adds a stock] if the company has an excellent reputation, demonstrates sustained growth, and is of interest to a large number of investors
Johnson & Johnson to Host Investor Conference Call on Second-Quarter Results
04:30pm, Tuesday, 04'th Jun 2024
NEW BRUNSWICK, N.J.--(BUSINESS WIRE)--Johnson & Johnson (NYSE: JNJ) will host a conference call for investors at 8:30 a.m. (Eastern Time) on Wednesday, July 17th to review second-quarter results. Joaq
The 3 Most Undervalued Dow Stocks to Buy in June 2024
10:00am, Tuesday, 04'th Jun 2024
With a wild positive finish on the last trading day of May 2024, thanks in part to some decent inflation data, investors now set their sights on the summer months. While it was a somewhat nail-biting
Cramer's Mad Dash: Johnson & Johnson
09:52am, Tuesday, 04'th Jun 2024
CNBC's Jim Cramer delivers his daily Mad Dash.
3 Dividend Aristocrats to Scoop Up During Market Pullbacks in June
06:00am, Tuesday, 04'th Jun 2024
If you are worried about the economy and how the market will move from here, it is ideal to invest in dividend stocks that pay, no matter the market situation. When you have dividend aristocrat sto
Oregon Jury Awards $260 Million in Mesothelioma Case Against Johnson & Johnson
10:26pm, Monday, 03'rd Jun 2024
PORTLAND, Ore.--(BUSINESS WIRE)--A jury in Portland, Ore., has found in favor of a mother of three suffering from the deadly cancer mesothelioma and ordered Johnson & Johnson to pay her $260 million.
